1 – 43 of 43
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
The anti-leprosy drug clofazimine reduces polyQ toxicity through activation of PPARγ
(
- Contribution to journal › Article
- 2023
-
Mark
Altered Adipocyte Cell Size Distribution Prior to Weight Loss in the R6/2 Model of Huntington's Disease
(
- Contribution to journal › Article
-
Mark
Comorbidities and clinical outcomes in adult- and juvenile-onset Huntington’s disease : a study of linked Swedish National Registries (2002–2019)
(
- Contribution to journal › Article
-
Mark
Effects of mutant huntingtin in oxytocin neurons on non-motor features of Huntington's disease
(
- Contribution to journal › Article
-
Mark
Mechanisms underlying metabolic alterations in Huntington's disease. Beyond the brain and back.
2023) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
- 2022
-
Mark
Decreased CSF oxytocin relates to measures of social cognitive impairment in Huntington's disease patients
(
- Contribution to journal › Article
- 2020
-
Mark
Development and Applications of in vitro Models to Study Human Brain Evolution and Disease
2020) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
No symphony without bassoon and piccolo : Changes in synaptic active zone proteins in Huntington's disease
(
- Contribution to journal › Article
-
Mark
Imbalance of the oxytocin-vasopressin system contributes to the neuropsychiatric phenotype in the BACHD mouse model of Huntington disease
(
- Contribution to journal › Article
- 2019
-
Mark
Leptin deficiency reverses high metabolic state and weight loss without affecting central pathology in the R6/2 mouse model of Huntington's disease
(
- Contribution to journal › Article
-
Mark
The Role of Hypothalamic Pathology for Non-Motor Features of Huntington's Disease
(
- Contribution to journal › Scientific review
- 2018
-
Mark
Perturbations in the p53/miR-34a/SIRT1 pathway in the R6/2 Huntington's disease model
(
- Contribution to journal › Article
-
Mark
mHTT Seeding Activity : A Marker of Disease Progression and Neurotoxicity in Models of Huntington's Disease
(
- Contribution to journal › Article
-
Mark
A critical evaluation of wet biomarkers for huntington's disease : Current status and ways forward
(
- Contribution to journal › Scientific review
-
Mark
Huntingtin Aggregation Impairs Autophagy, Leading to Argonaute-2 Accumulation and Global MicroRNA Dysregulation
(
- Contribution to journal › Article
-
Mark
Brain pericyte activation occurs early in Huntington's disease
(
- Contribution to journal › Article
- 2017
-
Mark
Alterations of striatal indirect pathway neurons precede motor deficits in two mouse models of Huntington's disease
(
- Contribution to journal › Article
- 2016
-
Mark
Mitochondrial Respiratory Function in Peripheral Blood Cells from Huntington's Disease Patients
(
- Contribution to journal › Article
-
Mark
Subjective sleep problems in Huntington's disease : A pilot investigation of the relationship to brain structure, neurocognitive, and neuropsychiatric function
(
- Contribution to journal › Article
- 2014
-
Mark
A peripheral immune response in Huntington's disease and delineation of its importance in disease pathology
(
- Thesis › Doctoral thesis (compilation)
-
Mark
HTT-lowering reverses Huntington's disease immune dysfunction caused by NF kappa B pathway dysregulation
(
- Contribution to journal › Article
-
Mark
Plasma Melatonin Is Reduced in Huntington's Disease
(
- Contribution to journal › Article
- 2013
-
Mark
Differences Between Parkinson's and Huntington's Diseases and Their Role for Prioritization of Stem Cell-Based Treatments
(
- Contribution to journal › Article
- 2012
-
Mark
Neuronal Properties, In Vivo Effects, and Pathology of a Huntington's Disease Patient-Derived Induced Pluripotent Stem Cells
(
- Contribution to journal › Article
- 2009
-
Mark
Increased numbers of motor activity peaks during light cycle are associated with reductions in adrenergic alpha(2)-receptor levels in a transgenic Huntington's disease rat model
(
- Contribution to journal › Article
- 2008
-
Mark
Beyond the basal ganglia
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Mutant huntingtin can paradoxically protect neurons from death
(
- Contribution to journal › Scientific review
- 2007
-
Mark
Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidates
(
- Contribution to journal › Article
-
Mark
Decreased VIP and VPAC(2) receptor expression in the biological clock of the R6/2 Huntington's disease mouse
(
- Contribution to journal › Article
-
Mark
Communication breakdown - synaptic dysfunction in Huntington's disease.
2007)(
- Thesis › Doctoral thesis (compilation)
- 2005
-
Mark
Depletion of rabphilin 3A in a transgenic mouse model (R6/1) of Huntington's disease, a possible culprit in synaptic dysfunction.
(
- Contribution to journal › Article
-
Mark
Synaptic dysfunction in Huntington's disease: a new perspective
(
- Contribution to journal › Scientific review
-
Mark
Reduced hippocampal neurogenesis in R6/2 transgenic Huntington's disease mice.
(
- Contribution to journal › Article
- 2004
-
Mark
Harnessing endogenous stem cells to treat neurodegenerative disorders of the basal ganglia.
(
- Contribution to journal › Article
- 2002
-
Mark
Evidence for Dysfunction of the Nigrostriatal Pathway in the R6/1 Line of Transgenic Huntington's Disease Mice.
(
- Contribution to journal › Article
- 2001
-
Mark
Mice transgenic for exon 1 of the Huntington's disease gene display reduced striatal sensitivity to neurotoxicity induced by dopamine and 6-hydroxydopamine
(
- Contribution to journal › Article
-
Mark
Resistance to NMDA toxicity correlates with appearance of nuclear inclusions, behavioural deficits and changes in calcium homeostasis in mice transgenic for exon 1 of the huntington gene
(
- Contribution to journal › Article
-
Mark
Partial resistance to malonate-induced striatal cell death in transgenic mouse models of Huntington's disease is dependent on age and CAG repeat length
(
- Contribution to journal › Article
-
Mark
Effects of dopamine and excitotoxicity in experimental models of Huntington's disease
2001)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Neuronal Cell Death and Restoration in the Basal Ganglia: Implications for Huntington's and Parkinson's diseases
2001)(
- Thesis › Doctoral thesis (compilation)
- 2000
-
Mark
Oxidative stress, mitochondrial permeability transition and activation of caspases in calcium ionophore A23187-induced death of cultured striatal neurons
(
- Contribution to journal › Article
- 1996
-
Mark
Parameters affecting the survival of cultured and grafted embryonic neurons
1996)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Protection of Striatal and Nigral neurons by Trophic and Antioxidant Mechanisms. A study on in vitro and in vivo brain insult models and neural transplants
1996)(
- Thesis › Doctoral thesis (compilation)